D.A. DAVIDSON & CO. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2017$17,000
-71.7%
1,000
-81.6%
0.00%
-100.0%
Q1 2017$60,000
+9.1%
5,446
+41.3%
0.00%0.0%
Q4 2016$55,000
-62.3%
3,855
-35.5%
0.00%
-75.0%
Q3 2016$146,000
+50.5%
5,980
+22.6%
0.00%
+33.3%
Q2 2016$97,000
-1.0%
4,877
+30.0%
0.00%0.0%
Q1 2016$98,000
-39.1%
3,752
+135.7%
0.00%
-40.0%
Q4 2015$161,000
-97.3%
1,592
-95.2%
0.01%
-97.6%
Q3 2015$5,942,000
-20.3%
33,318
-0.7%
0.21%
-15.1%
Q2 2015$7,452,000
+8.4%
33,552
-3.1%
0.24%
+8.4%
Q1 2015$6,876,000
+38.9%
34,630
+0.1%
0.23%
+39.5%
Q4 2014$4,951,000
+13.1%
34,609
+3.7%
0.16%
+9.5%
Q3 2014$4,379,000
+1.8%
33,388
-2.1%
0.15%
+1.4%
Q2 2014$4,300,000
-3.9%
34,118
+0.4%
0.15%
-8.8%
Q1 2014$4,476,000
+10.6%
33,976
-1.5%
0.16%
+6.0%
Q4 2013$4,047,000
+13.6%
34,490
+1.0%
0.15%
-5.6%
Q3 2013$3,561,000
+23.8%
34,151
+2.1%
0.16%
+15.1%
Q2 2013$2,877,00033,4430.14%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2017
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders